Pozen Inc. v. Par Pharmaceutical, Inc., No. 6:08-cv-00437 (E.D. Tex. Aug. 5, 2011)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS TYLER DIVISION POZEN INC. Plaintiff, vs. PAR PHARMACEUTICAL, INC., ALPHAPHARM PTY LTD., TEVA PHARMACEUTICALS USA INC., DR. REDDY’S LABS., INC. Defendants. § § § § CASE NO. 6:08 CV 437 § PATENT CASE § § CONSOLIDATED WITH § CASE NO. 6:09 CV 3 AND § CASE NO. 6:09 CV 182 § § § § FINDINGS OF FACT AND CONCLUSIONS OF LAW This case involves a dispute over obtaining approval to market and sell generic drugs under the Hatch-Waxman Act. Pozen Inc.